NCT00475501 - 5-Alpha Reductase and Anabolic Effects of Testosterone | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2012

Study Completion Date

October 31, 2014

Conditions

Male HypogonadismMuscle AtrophySarcopeniaBenign Prostate Hypertrophy

Interventions

DRUG

Testosterone Enanthate

125 mg, i.m. injection, once/week, for 52 weeks

DRUG

Finasteride

5 mg, oral, once/day, for 52 weeks

OTHER

Placebo

Trial Locations (1)

North Florida/South Georgia Veterans Health System, Gainesville